Nearly four months after teaming up with Celgene, Presage Biosciences has snagged another major cancer player as a partner: Bristol-Myers Squibb. The Big Pharma will use Presage’s microdosing ...
Cryptopolitan on MSN
Crypto news: This under $0.05 altcoin sells out phase 6 in record time as Cardano (ADA) stagnates
The crypto news today revolves around two events. Cardano is under pressure because the price of ADA has dropped. The other ...
TGW211 is a next-generation, first-in-class HER2-directed radioimmunoconjugate developed based on Tagworks' proprietary Click-to-Release – bioorthogonal, in vivo click chemistry – linker platform ...
EORTC 1709/CCTG CE.8: A phase III trial of marizomib in combination with temozolomide-based radiochemotherapy versus temozolomide-based radiochemotherapy alone in patients with newly diagnosed ...
The clinical relevance of margins in frameless stereotactic radiosurgery for intact brain metastases: A randomized trial of 0 vs 2 mm margins. This is an ASCO Meeting Abstract from the 2023 ASCO ...
Cryptopolitan on MSN
Mutuum Finance (MUTM) price prediction: Why this $0.04 token could surge 75x by 2026 as phase 7 gains momentum
Crypto news today shows that many investors want strong gains when 2026 arrives. While big names move slowly, new DeF ...
The results of the first 'Phase 0' clinical trial in oncology of a therapeutic agent under the Exploratory Investigational New Drug Guidance of the US FDA have ...
Aster price hovered above $0.70 following a 2.67% daily gain, supported by a bullish market trend. The move follows the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback